Pay in 4 interest-free payments of $5.69 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
If symptoms persist beyond 12 weeks or significantly affect quality of life, consult your GP
This effect helps explain why nausea, vomiting, bloating, constipation, and other digestive symptoms can occur, especially during dose escalation or at higher doses
Survodutide for the treatment of obesity: rationale and design of the SYNCHRONIZE Cardiovascular Outcomes Trial
In TRIUMPH-3, the most commonly reported adverse events included diarrhea, nausea, constipation, and decreased appetite
A crossover study in subjects with type 2 diabetes has demonstrated that treatment with liraglutide (assessed at the dose escalation steps of 0.6, 1.2 and 1.8 mg) reduces fasting as well as postprandial glucose excursions following a standardised meal, relative to placebo [61]
